#52769
#52770
Re: Farmas USA
#52771
Re: Farmas USA
#52772
Re: Farmas USA
Documento de la OMS acerca del Ebola, del 23 de Octubre
http://apps.who.int/iris/bitstream/10665/137184/1/WHO_EVD_Meet_EMP_14.2_eng.pdf?ua=1
A destacar, importante:
Impact of vaccines on further evolution of the epidemic
The meeting concluded that vaccines will have a significant impact on the further evolution of the epidemic in any scenario, from best-case to worst-case.
Financing of vaccine development, clinical trials, and vaccination
campaigns
The meeting concluded that funding issues should not be allowed to dictate the vaccine agenda. The funds will be found
The timing and quantity of vaccine supplies
The meeting concluded that the timing and quantity of vaccine doses should not constrain the design of clinical trials. Industry confirmed that enough vaccine doses would be available.
- GlaxoSmithKline’s monthly production capacity for purified bulk vaccine was expected to rise from the current figure of 24,000 doses to 230,000 by April 2015, if they can be filled for release.
- NewLink’s bulk vaccine manufacturing capacity for the Canadian vaccine was noted to vary, according to the dose selected, from 52,000 doses to 5.2 million doses anticipated for the first quarter of 2015.
De ser cierto como espabilan aqui algunas farmas ...
#52773
Re: Farmas USA
#52774
Re: Farmas USA
ZGNX
Gracias Jleon Y 7Soles, la verdad que lei con prisas el curro no me deja hacer análisis profundos
.
Sigo pensando que el Smartmoney que ya esta presente en un 62%, ha entrado por algo ,esos no se juegan esos millonzacos si no es que ven altas probabilidades, igual pienso de compra de esa farma con Orphan Drug en F-2 , mas cuando el Smartmoney tiene derecho de voto y son los que deciden y no su directiva
#52775
Re: Farmas USA
#52776